Irritable Bowel Syndrome
Public-private partnership initiative develops core diagnostic criteria for abdominal, pelvic, and urogenital pain associated with irritable bowel syndrome.
The FDA has accepted the supplemental New Drug Application for Trulance for the treatment of irritable bowel syndrome with constipation.
The efficiency of self-administered hypnotherapy is equivalent to that of in-office hypnotherapy in relieving pediatric irritable bowel syndrome or functional abdominal pain.
Probiotics may alleviate pain in the short-term in children with recurrent abdominal pain.
The FDA is warning patients and healthcare professionals that Viberzi tablets should not be used in patients without a gallbladder due to an increased risk of developing serious pancreatitis
Most frequent upper functional GI disorders in IBS were functional dyspepsia, belching disorders
Tarantula toxin specifically mediates mechanonociception
Clinical Pain Advisor Articles
- Non-Opioid Therapies for Pain Management in the ED
- Betel Quid Addiction and Implications for Substance Use Disorder
- Low Back Pain: Contributing Factors, Prophylactic Strategies, and Effective Treatments
- Peripherally Acting Opioid and Cannabinoid May Be Effective for Neuropathic Pain
- New Blood Test Shows High Accuracy for Diagnosing Fibromyalgia
- Exploring the Connections Between Neuropathic Pain and Comorbid Mood Disorders
- Medical Marijuana Laws, Dispensaries May Reduce Deaths From Opioid Overdose
- Ketamine Infusion May Be Effective for the Short-Term Relief of CRPS-Associated Pain
- An Avenue for the Development of Opioid Adjuncts for Enhanced Analgesia, Reduced Abuse Potential
- Peripheral Neuropathy Management in the Primary Care Setting: A Guide
- Opioids vs Nonopioid Medications for Chronic Back, Knee, and Hip Osteoarthritis Pain
- Conventional vs High-Frequency Spinal Cord Stimulation for Chronic Pain
- Evaluating Headache in the Elderly: Primary vs Secondary Causes
- Custom Foot Orthotics vs OTC Insoles for Plantar Heel Pain
- Once-Monthly Erenumab Injections May Be Effective for Episodic Migraine Prophylaxis